Trial intelligence / Profile preview

MultiHance vs Magnevist in Brain MRI at 3T

NCT00395863Phase 4Completed

Sponsor
Bracco Diagnostics Inc.
Start
Nov 2006
Primary completion
Feb 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of gadobenate dimeglumine in brain tumor, sponsored by Bracco Diagnostics Inc.. Started Nov 2006; status: completed.

02

Drugs

gadobenate dimeglumine
03

Conditions

brain tumor

Beyond the preview

Go deeper on NCT00395863.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00395863.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call